Innopharmax Inc.

  • Biotech or pharma, therapeutic R&D
  • Other R&D services

INNOPHARMAX is a clinical-stage pharmaceutical company (TPEx: 4172) focused on development and commercialization of ORAL new dosage form products. At BIO 2025, we focus on Assets for licensing and co-development in Oncology, Diabetes/Obesity, Hypertension, etc.

Address

Taipei
Taiwan

Website

http://www.innopharmax.com/

Contact Exhibitor


Loading
View all Partnering Companies

white squarewhite

BIO DOUBLE HELIX SPONSORS

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

BIO HELIX SPONSORS

Loading